Kevin Herde serves as the Chief Financial Officer at Maravai LifeSciences Holdings Inc., a role he has held since joining the company in 2015. With a robust background in finance and strategic planning, Herde has been instrumental in guiding Maravai through its significant growth phases, including its successful initial public offering (IPO) in November 2020. Prior to Maravai, Herde spent over a decade at Life Technologies, where he held various senior finance positions, culminating in his role as Vice President of Finance. His experience at Life Technologies provided him with deep insights into the life sciences industry, which he has effectively leveraged at Maravai. At Maravai LifeSciences, Herde's responsibilities extend beyond traditional CFO duties. He plays a critical role in shaping the company's strategic direction, overseeing financial planning and analysis, and ensuring robust financial controls. His leadership has been pivotal in driving Maravai's financial performance, evidenced by the company's consistent revenue growth and strong market position. Under his stewardship, Maravai has not only expanded its product offerings but also enhanced its operational efficiency, positioning the company as a leader in the life sciences sector. Herde's strategic foresight and financial acumen continue to be key assets for Maravai as it navigates the dynamic landscape of the biotechnology industry.